ZInvestorHunting

Helen H. Liang

Solo GP · Menlo Park, California

US Angel

Named as the only individual (Managing Director of the General Partner of the Issuer) on the Form D for FoundersX Growth D, L.P., a $50M venture fund (Apr 2024). Also a non-executive director at 3 startups that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

82/ 100
High Conviction AngelLatest deal Apr 2025
Deal VelocityLatest deal Apr 2025USA & Europe pipeline
Typical Check$500K–$1.5MPre-Seed / Seed
Primary FocusHealthcare, Biotech & PharmaPre-seed to Growth
Direct AccessWarm Intro Recommended1-click pitch match

Why Helen H. Liang holds a 82/100 confidence score

  • Verified past startup investments on public record
  • Target check sizes calibrated between $500K–$1.5M
  • Clear domain thesis in Healthcare, Biotech & Pharma
  • Named as the only individual (Managing Director of the General Partner of the Issuer) on the Form D for FoundersX Growth D, L.P., a $50M venture fund (Apr 2024). Also a non-executive director at 3 startups that filed Form D.

Building in Healthcare, Biotech & Pharma? See how well your pitch deck matches Helen H. Liang’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (Managing Director of the General Partner of the Issuer) on the Form D for FoundersX Growth D, L.P., a $50M venture fund (Apr 2024). Also a non-executive director at 3 startups that filed Form D.

Source: SEC Form D: FoundersX Growth D, L.P. (Apr 23, 2024) · 3 more sources

Stages
Pre-seed to Growth
Typical check (est.)
$500K–$1.5M
Verified deals
4 on file
Latest activity
Apr 2025
Pitch Readiness

Is Helen H. Liang a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Helen H. Liang back?

HealthcareBiotech & Pharma

Verified investments & deal activity

4 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • Cognito Therapeutics Group

    Board seat on the company's SEC filing · MA

    Apr 2025
  • FS2 Business

    Board seat on the company's SEC filing · MO

    Jan 2025
  • Markable

    Board seat on the company's SEC filing · WA

    Jun 2024
  • FoundersX Growth D, L.P.

    Invested through a fund

    Apr 2024

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Helen H. Liang

Founders raising in health and bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
Suzanne Fletcher

Solo GP · Portola Valley, CA

86/100
$300K–$900KActive Mar 2026
HealthcareAI & MLFintech+1
Adam Rosenwach

Solo GP · New York, NY

85/100
Active Jun 2026
Biotech & PharmaHealthcare
Matthew Hellauer

Solo GP · Baltimore, MD

87/100
Active Jun 2026
HealthcareBiotech & Pharma
John Parker

Solo GP · Sudbury, MA

86/100
$200K–$600KActive Nov 2025
HealthcareBiotech & Pharma
Patrick Gallagher

Syndicate lead · Austin, TX

90/100
$165K–$2.25MActive Aug 2026
Biotech & PharmaHealthcare
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Helen H. Liang and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.